Trikafta, made by Vertex Pharmaceuticals, is, as its name suggests, a combination of three drugs. It works for 90 percent of patients with cystic fibrosis, and will be priced at $311,000 per year.

But when she found out about the drug Trikafta, she started thinking, “we can manage this”. Cystic fibrosis is a condition that produces thick and sticky mucus and mainly affects the lungs and ...

The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...

Cystic fibrosis has traditionally been considered a fatal disease. But thanks to medical advancements and treatments, many patients now live longer, healthier lives. Patients in Saskatchewan may ...